MBX Biosciences Inc (MBX) PT Raised to $88 at Truist Securities
August 10, 2026 7:22 AM
Truist Securities analyst Srikripa Devarakonda raised the price target on MBX Biosciences Inc (NASDAQ: MBX) to $88.00 (from $70.00) while maintaining a Buy rating.
